{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:12:21Z","timestamp":1792660341177,"version":"4.5.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2019.00527","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T11:30:46Z","timestamp":1560252646000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Broad Lipidomic and Transcriptional Changes of Prophylactic PEA Administration in Adult Mice"],"prefix":"10.3389","volume":"13","author":[{"given":"Raissa","family":"Lerner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Pascual Cuadrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bindila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2015.00026","article-title":"Goals in nutrition science 2015\u20132020.","volume":"2","author":"Allison","year":"2015","journal-title":"Front. Nutr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"C145","DOI":"10.1007\/BF01972748","article-title":"A proposed autacoid mechanism controlling mastocyte behaviour.","volume":"39","author":"Aloe","year":"1993","journal-title":"Agents Actions"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19072148","article-title":"The peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) agonist pemafibrate protects against diet-induced obesity in mice.","volume":"19","author":"Araki","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B4","first-page":"353","article-title":"Efficacy of palmitoylethanolamide for pain: a meta-analysis.","volume":"20","author":"Artukoglu","year":"2017","journal-title":"Pain Physician"},{"key":"B5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0166-2236(00)01682-9","article-title":"BDNF and epilepsy: Too much of a good thing?","volume":"24","author":"Binder","year":"2001","journal-title":"Trends Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-4939-3539-0","article-title":"Extraction and simultaneous quantification of endocannabinoids and endocannabinoid-like lipids in biological tissues.","volume":"1412","author":"Bindila","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.atherosclerosis.2012.07.038","article-title":"Acyl chain-dependent effect of lysophosphatidylcholine on cyclooxygenase (COX)-2 expression in endothelial cells.","volume":"224","author":"Brki\u0107","year":"2012","journal-title":"Atherosclerosis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.immuni.2013.10.010","article-title":"The spleen in local and systemic regulation of immunity.","volume":"39","author":"Bronte","year":"2013","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/sj.bjp.0704466","article-title":"Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat.","volume":"135","author":"Conti","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1124\/jpet.107.123265.distinct","article-title":"Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-\u03b1 agonist, modulates carrageenan-Induced Paw Edema in Mice.","volume":"322","author":"D\u2019Agostino","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejphar.2009.04.022","article-title":"Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kB nuclear signalling in dorsal root ganglia.","volume":"613","author":"D\u2019Agostino","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/bj3580249","article-title":"Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.","volume":"358","author":"Di Marzo","year":"2001","journal-title":"Biochem. J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3109\/08830189809043005","article-title":"Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.","volume":"16","author":"Dinarello","year":"1998","journal-title":"Int. Rev. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1073\/pnas.92.8.3376","article-title":"Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.","volume":"92","author":"Facci","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s11064-004-6871-3","article-title":"Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A 2.","volume":"29","author":"Farooqui","year":"2004","journal-title":"Neurochem. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/jcb.20053","article-title":"Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system.","volume":"92","author":"Goetzl","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.expneurol.2010.03.022","article-title":"Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain.","volume":"224","author":"Hansen","year":"2010","journal-title":"Exp. Neurol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02671","article-title":"Prophylactic palmitoylethanolamide prolongs survival and decreases detrimental inflammation in aged mice with bacterial meningitis.","volume":"9","author":"Heide","year":"2018","journal-title":"Front. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/oby.2008.591","article-title":"Anti-inflammatory effect of palmitoylethanolamide on human adipocytes.","volume":"17","author":"Hoareau","year":"2009","journal-title":"Obesity"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191363","article-title":"Hippocampal corticotropin-releasing hormone neurons support recognition memory and modulate hippocampal excitability.","volume":"13","author":"Hooper","year":"2018","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.plipres.2016.02.002","article-title":"Endocannabinoids and endocannabinoid-related mediators: targets, metabolism and role in neurological disorders.","volume":"62","author":"Iannotti","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/151028","article-title":"Palmitoylethanolamide: a natural body-own anti-inflammatory agent, effective and safe against influenza and common cold.","volume":"2013","author":"Keppel Hesselink","year":"2013","journal-title":"Int. J. Inflam."},{"key":"B23","doi-asserted-by":"publisher","first-page":"851","DOI":"10.4049\/jimmunol.1302831","article-title":"The autotaxin-LPA axis emerges as a novel regulator of lymphocyte homing and inflammation.","volume":"192","author":"Knowlden","year":"2014","journal-title":"J. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1046\/j.1528-1157.2001.41499.x","article-title":"Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.","volume":"42","author":"Lambert","year":"2001","journal-title":"Epilepsia"},{"key":"B25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1194\/jlr.M080093","article-title":"Simultaneous lipidomic and transcriptomic profiling in mouse brain punches of acute epileptic seizure model compared to controls.","volume":"59","author":"Lerner","year":"2018","journal-title":"J. Lipid Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bbalip.2016.11.008","article-title":"Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry.","volume":"1862","author":"Lerner","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"B27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method.","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1124\/mol.104.006353.dyshev","article-title":"The nuclear receptor peroxisome proliferator-activated receptor- \u03b1 mediates the anti-inflammatory actions of palmitoylethanolamide.","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1124\/jpet.106.111385","article-title":"Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha.","volume":"319","author":"LoVerme","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0845-5","article-title":"Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner.","volume":"17","author":"Lowin","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.phrs.2014.05.006","article-title":"Palmitoylethanolamide in CNS health and disease.","volume":"86","author":"Mattace Raso","year":"2014","journal-title":"Pharmacol. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nri1669","article-title":"Structure and function of the spleen.","volume":"5","author":"Mebius","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s13311-016-0420-z","article-title":"Oral palmitoylethanolamide treatment is associated with reduced cutaneous adverse effects of interferon-1a and circulating proinflammatory cytokines in relapsing\u2013remitting multiple sclerosis.","volume":"13","author":"Orefice","year":"2016","journal-title":"Neurotherapeutics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/bph.13580","article-title":"The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.","volume":"174","author":"Petrosino","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00067","article-title":"Antiepileptogenic effect of subchronic palmitoylethanolamide treatment in a mouse model of acute epilepsy.","volume":"11","author":"Post","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1161\/ATVBAHA.118.311185","article-title":"Palmitoylethanolamide promotes a proresolving macrophage phenotype and attenuates atherosclerotic plaque formation.","volume":"38","author":"Rinne","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1254\/jphs.11150FP","article-title":"N-Palmitoyl-ethanolamine (PEA) induces peripheral antinociceptive effect by ATP-sensitive K+-channel activation.","volume":"118","author":"Romero","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor.","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/jcb.20128","article-title":"Lysophospholipids in development?: miles apart and edging in.","volume":"992","author":"Saba","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/978-3-319-57371-7_12","article-title":"Mast cells and glia as targets for the anandamide congener palmitoylethanolamide: An anti-inflammatory and neuroprotective lipid signaling molecule","author":"Skaper","year":"2017","journal-title":"Endocannabinoids and Lipid Mediators in Brain Functions"},{"key":"B41","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrn3085","article-title":"A pathophysiological framework of hippocampal dysfunction in ageing and disease.","volume":"12","author":"Small","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9173090","article-title":"Autotaxin-lysophosphatidic acid: from inflammation to cancer development.","volume":"2017","author":"Vald\u00e9s-Rives","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.prostaglandins.2008.03.002","article-title":"p38 kinase\/cytosolic phospholipase A2\/cyclooxygenase-2 pathway: a new signaling cascade for lipopolysaccharide-induced interleukin-1\u03b2 and interleukin-6 release in differentiated U937 cells.","volume":"86","author":"Wang","year":"2008","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B44","first-page":"22","article-title":"Innate and adaptive processes in the spleen.","volume":"11","author":"Wluka","year":"2006","journal-title":"Ann. Transplant."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.00527\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T11:30:49Z","timestamp":1560252649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.00527\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":44,"alternative-id":["10.3389\/fnins.2019.00527"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2019.00527","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"article-number":"527"}}